Clinical trials by condition
Neurofibromatosis clinical trials near you
22 studies for neurofibromatosis are recruiting volunteers at 62 research sites in 24 states.
Also called Neurofibromatosis syndrome.
- Studies recruiting
- 22
- Research sites
- 62
- States
- 24
What is neurofibromatosis?
Neurofibromatosis is a genetic disorder of the nervous system. It mainly affects how nerve cells form and grow, and it causes tumors to grow on nerves. The tumors are usually benign, meaning not cancer, but sometimes they can become cancerous.
It can be passed down from a parent or happen because of a change in a person's genes, and someone who has it can pass it to their children. There are three types. Type 1 (NF1) causes skin changes and deformed bones and usually starts in childhood. Type 2 (NF2) causes hearing loss, ringing in the ears and poor balance, often starting in the teen years. Schwannomatosis, the rarest type, causes intense pain.
There is no cure, but treatment can help control symptoms. Depending on the type and how serious it is, treatment may include surgery to remove tumors, radiation therapy and medicines.
Written with AI from MedlinePlus, the National Library of Medicine's health information, and checked by an AI medical reviewer on November 13, 2026. Read more on MedlinePlus
Types of neurofibromatosis
Each type has its own page with the studies recruiting for it. The figures on this page include them.
- Neurofibromatosis type 1 (NF1)not enough studies for a page yet
Areas with the most neurofibromatosis studies
Metro areas where studies for neurofibromatosis are recruiting, each study counted once in an area.
By state
Studies for neurofibromatosis recruiting in each state.
- Maryland12 studies · 7 sites
- California7 studies · 7 sites
- District of Columbia6 studies · 2 sites
- Indiana5 studies · 4 sites
- New York5 studies · 8 sites
- Pennsylvania5 studies · 1 site
- Texas5 studies · 4 sites
- Massachusetts4 studies · 3 sites
- Ohio4 studies · 1 site
- Illinois3 studies · 3 sites
Whom the studies accept
The share of the neurofibromatosis studies open to each group. A study can accept several.
- Adults 18 to 6491%
- Adults 65 and over82%
- Children and teens (under 18)73%
- Healthy volunteers14%
- Open to all sexes100%
Study phases
Earlier phases test safety in fewer people; later phases compare a treatment with the usual care in many.
- Phase 19%
- Phase 1/214%
- Phase 223%
- No phase (device, behavioral and other studies)18%
- Not stated36%
Cite these figures
Free to use under CC BY 4.0. Please credit LocalTrial with a link to this page.
Source: LocalTrial, Neurofibromatosis clinical trials near you, https://www.localtrial.com/clinical-trials/conditions/neurofibromatosis, updated November 13, 2026.
Source: <a href="https://www.localtrial.com/clinical-trials/conditions/neurofibromatosis">LocalTrial, Neurofibromatosis clinical trials near you</a>, updated November 13, 2026.
About these figures
Counted from ClinicalTrials.gov, the U.S. registry of clinical studies, for studies recruiting in the United States that study neurofibromatosis. A study is counted once however many sites it has.
Updated November 13, 2026.
These figures describe studies, not advice. Talk to your doctor before joining one.
Tell us a little about yourself and we'll suggest the neurofibromatosis studies near you that may fit. Free and private.
Ready to see what's near you?
Find neurofibromatosis studies near me